About (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine
(Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine (PubChem CID 167161061) has the molecular formula C11H17N5
and a molecular weight of 219.29 g/mol. Its IUPAC name is (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine.
Analyze (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine?
The IUPAC name of (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine (CID 167161061) is (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine.
What is the SMILES notation for (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine?
The canonical SMILES for (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine is CN(C)/C(=C\N1CCC=N1)c1cnn(C)c1.
What is the InChIKey of (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine?
The InChIKey is AZWKAQDOMQDEQS-LUAWRHEFSA-N. The full InChI is InChI=1S/C11H17N5/c1-14(2)11(9-16-6-4-5-12-16)10-7-13-15(3)8-10/h5,7-9H,4,6H2,1-3H3/b11-9-.
What are the key properties of (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine?
(Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine has a molecular weight of 219.29 g/mol, XLogP of 0.97, 3 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (Z)-2-(3,4-dihydropyrazol-2-yl)-N,N-dimethyl-1-(1-methylpyrazol-4-yl)ethenamine is sourced from PubChem (CID 167161061), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).